Risk of Hemolytic Uremic Syndrome Related to Treatment of <i>Escherichia coli</i> O157 Infection with Different Antimicrobial Classes

Risk of Hemolytic Uremic Syndrome Related to Treatment of <i>Escherichia coli</i> O157 Infection with Different Antimicrobial Classes

Treatment of Shiga toxin-producing <i>Escherichia coli</i> O157 (O157) diarrhea with antimicrobials might alter the risk of hemolytic uremic syndrome (HUS). However, full characterization of which antimicrobials might affect risk is lacking, particularly among adults. To inform clinical...

Full description

Bibliographic Details
Main Authors: Rajal K. Mody, Robert M. Hoekstra, Magdalena Kendall Scott, John Dunn, Kirk Smith, Melissa Tobin-D’Angelo, Beletshachew Shiferaw, Katie Wymore, Paula Clogher, Amanda Palmer, Nicole Comstock, Kari Burzlaff, Sarah Lathrop, Sharon Hurd, Patricia M. Griffin
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Microorganisms
Subjects:
hemolytic uremic syndrome
<i>Escherichia coli</i> O157
diarrhea
Online Access:https://www.mdpi.com/2076-2607/9/9/1997

Internet

https://www.mdpi.com/2076-2607/9/9/1997

Similar Items